- Global Pharma News & Resources

Brain Metastasis Pipeline Insights, 2019 Report -

The "Brain Metastasis - Pipeline Insight, 2019" drug pipelines has been added to's offering.

"Brain Metastasis - Pipeline Insight, 2019" report offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Brain Metastasis development.

The report provides detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule type.

Pipeline therapeutics development coverage provides descriptive product profiles including (but not limited to) drug description, product development and R&D activities encompassing clinical and pre-clinical studies, designations, collaborations, licensing deals, grants, technologies and patent details.

The report assesses the active Brain Metastasis pipeline products by developmental stage, product type, molecule type, and administration route.

Key Topics Covered:

1. Report Introduction

2. Brain Metastasis Overview

3. Pipeline Therapeutics

  • An Overview of Pipeline Products for Brain Metastasis

4. Comparative Analysis

5. Products in Clinical Stage

  • Product Description
  • Research and Development
  • Product Development Activities

6. Products in Pre-Clinical and Discovery Stage

  • Product Description
  • Research and Development
  • Product Development Activities

7. Therapeutic Assessment

  • Assessment by Route of Administration
  • Assessment by Stage and Route of Administration
  • Assessment by Molecule Type
  • Assessment by Stage and Molecule Type

8. Inactive Products

  • Product Description
  • Research and Development
  • Product Development Activities

Companies Mentioned

  • AbbVie Inc.
  • AngioChem Inc.
  • BBB Therapeutics B.V.
  • biOasis Technologies Inc.
  • Bristol-Myers Squibb Company
  • Diffusion Pharmaceuticals LLC
  • e-Therapeutics Plc
  • Exelixis Inc.
  • GlaxoSmithKline Plc
  • Hutchison MediPharma Limited
  • Komipharm International Co. Ltd.
  • Nektar Therapeutics
  • Nerviano Medical Sciences S.r.l.

For more information about this drug pipelines report visit

View source version on

Editor Details

Last Updated: 28-Jan-2019